Topical Delgocitinib for Facial Vitiligo
Topical Delgocitinib for Facial Vitiligo
Active, not recruiting · NCT07820098 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical Delgocitinib for Facial Vitiligo | Disease Attributes, Facies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Active, not recruiting | Phase 2 | 2026-09-15 | NCT07820098 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aage Bangs Fond | 1 |
| Gentofte Hospital, Denmark | 2 |
| Lone Skov | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Dermatology and Allergy Copenhagen University Hospital - Herlev and Gentofte | Gentofte Municipality | Denmark | 1 |